| Literature DB >> 33603600 |
Andrzej Berszakiewicz1,2, Aleksander Sieroń3, Zbigniew Krasiński4, Armand Cholewka5, Agata Stanek3.
Abstract
Compression therapy (CT) is an established treatment method in chronic venous disease. Despite years of clinical experience, choosing the optimum compression therapy, including grade and pressure distribution, which determine the efficacy of treatment poses a challenge. The paper discusses CT physical assumptions (stiffness, elasticity, static and dynamic stiffness indices), clinical effects and contraindications to CT. Copyright:Entities:
Keywords: chronic venous disease; compression therapy; interface pressure; stiffness
Year: 2019 PMID: 33603600 PMCID: PMC7874878 DOI: 10.5114/ada.2019.86990
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Stiffness classification according to the European Centre for Standardization (CEN) [10]
| Stiffness | Pressure [mm Hg] |
|---|---|
| Low | 0–2 |
| Medium | 2–4 |
| High | 4–6 |
Categories of compression materials [15]
| Extensibility | |||
|---|---|---|---|
| Inelastic | Short stretch | Intermediate stretch | Long stretch |
| 0 | < 70% | 70–140% | > 140% |
Interface pressure (IP) value and clinical effect of compression therapy [2, 7, 19, 24, 25]
| Clinical effect | IP range [mm Hg] | ||||
|---|---|---|---|---|---|
| 1–10 | 10–20 | 20–30 | 30–40 | > 40 | |
| Oedema reduction | Yes | Yes | Yes | Yes | Yes |
| Increased venous flow | Yes | Yes | Yes | Yes | |
| Improved microcirculation | Yes | Yes | Yes | ||
| Reduced vein diameter in a standing position | Yes | Yes | |||
Clinical benefits of compression therapy (CT) [2, 7, 12, 15, 23–25, 27, 30, 31, 34–37]
| Clinical benefits of compression therapy |
|---|
| Tissue effect
Endothelial cell activity stimulation: increased nitrous oxide production Inhibited lymphocyte adhesion Inhibited platelet aggregation Increased local and systemic fibrinolytic activity Decreased production of inflammatory cytokines Local increase in oxygen partial pressure Reduced tissue iron overload Reduced skin hemosiderin deposits Decreased reactive oxygen species production |
| Increased tissue pressure, reduced pericapillary oedema |
| Improved microcirculation |
| Oedema reduction (CT range of 40–60 mm Hg) |
| Reduced venous volume and diameter |
| Accelerated venous flow, normalised arteriovenous gradient |
| Peripheral blood volume shift to the central compartment |
| Reduced venous reflux, intravenous pressure and stasis volume |
| Venous pump improvement/normalisation |
| Improved arterial inflow (IPC) |
| Improved lymph drainage |
| Decreased size and softening of lipodermatosclerosis |
| Accelerated venous leg ulcer (VLU) healing |
| Increased bone density |
| Subjective symptom improvement (pain, heaviness, itch and cramps) |
| Better quality of life |
Contraindications to compression therapy (CT) [23, 24, 31]
| Absolute | Relative |
|---|---|
| 1. Severe heart failure concomitant with poorly controlled hypertension | 1. Lower extremity artery disease with ABPI < 0.8 |
| 2. Previous vascular and/or skin grafting procedure | 2. Paper thin skin, prone to injury (especially over the bony prominences) |
| 3. Severe all-cause peripheral neuropathy | 3. Limb deformity |
| 4. Acute skin and subcutaneous infections | 4. Chronic skin and subcutaneous infections |
| 5. Allergy to compression material | |
| 6. Lack of patient consent to treatment | |
| 7. Systolic pressure at the ankle level < 50 mm Hg | |
| 8. Active phlebitis and deep vein thrombosis |
Not true for IPC arterial systems.
Contraindication to intermittent pneumatic compression (IPC).